OraDisc™ B is a mucoadhesive erodible disc containing 15 mg of benzocaine which has been developed for the treatment of oral pain. The following charts demonstrate the dissolution profile of benzocaine in the OraDisc™ technology:

In addition, the collective assay results for both aged and fresh samples, prototype and preproduction, show no significant differences and remain well within specification.

A benzocaine disc represents a major advance in the treatment of oral pain, by providing a controlled amount of local anesthetic to the covered area without numbing the tongue and other parts of the oral cavity. This product will seek OTC regulatory status.